Evquiza intravenous infusion solution 345mg (YJ_code: 2189404A1020, standard: 345mg2.3mL1 bottle), from Ultragenyx Japan, contains Evinacumab (genetical recombination). This monoclonal antibody is approved as an adjunct to other LDL-C-lowering therapies for adults and pediatric patients aged 5 years and older with homozygous familial hypercholesterolemia (HoFH).
Evquiza intravenous infusion solution 345mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →